Recognition of sialic acid-containing glycoconjugates by the human gastric pathogen
Helicobacter pylori is a human-and primate-specific pathogen found in the gastric mucus layer or attached to the gastric epithelium. H. pylori infection, which affects about half the world population, results in chronic active gastritis and is a risk factor for the development of peptic ulcer disease, gastric adenocarcinoma, and gastric lymphoma (23) .
In order to initiate and maintain infection, microbes must first bind to receptors present on their target tissue. Therefore, interest has been directed to the elucidation of receptors for different microorganisms, many of which have been demonstrated to be glycosphingolipids (14, 25) . Initial studies of potential receptors for H. pylori suggested that acid glycosphingolipids, such as the GM3 ganglioside and sulfatide (7, 27) , can function as receptors for the bacterium. (The glycosphingolipid nomenclature follows the recommendations of the International Union of Pure and Applied Chemistry-International Union of Biochemistry Commission on Biochemical Nomenclature [Commission on Biochemical Nomenclature for Lipids] [5a, 5b, 5c] . It is assumed that Gal, Glc, GlcNAc, GalNAc, and NeuAc are of the D configuration; that Fuc is of the L configuration; and that all sugars are present in the pyranose form. In the shorthand nomenclature for fatty acids and bases, the number before the colon refers to the carbon chain length and the number after the colon gives the total number of double bonds in the molecule. Fatty acids with a 2-hydroxy group are denoted by the prefix h before the abbreviation, e.g., h16:0. For long-chain bases, d denotes dihydroxy and t denotes trihydroxy. Thus, d18:1 designates sphingosine [1,3-dihydroxy-2-aminooctadecene] and t18:0 designates phytosphingosine [1,3,4-trihydroxy-2-aminooctadecane].) Other receptors subsequently reported include gangliotetraosylceramide (17) , the Le b antigen (3), NeuAc␣3-neolactotetraosylceramide (20) , lactosylceramide (1) , and lactotetraosylceramide (38) . In a separate series of studies, the binding of H. pylori to sialic acid-containing glycoconjugates from a variety of origins was demonstrated (21, 22) . Two recent studies have demonstrated that the gangliosides sialyl-neolactohexosylceramide NeuAc␣3Gal␤4GlcNAc ␤3Gal␤4GlcNAc␤3Gal␤4Glc␤1Cer (26) and sialyl-dimericLewis x NeuAc␣3Gal␤4(Fuc␣3)GlcNAc␤3Gal␤4(Fuc␣3) GlcNAc␤3Gal␤4Glc␤1Cer (19) are high-affinity H. pylori receptors. The H. pylori adhesin (SabA) that mediates binding to sialyl-Le x , and the gene encoding it (sabA), were also identified in the second study.
The primary target tissue of H. pylori, i.e., the human gastric epithelium, has a very low content of sialic acid (18) . However, H. pylori also interacts with sialylated glycoconjugates of human neutrophil granulocytes (22) , and several of the identified H. pylori-binding gangliosides are also present in human neutrophils (32, 33) . The aim of the present study was to further investigate the structural requirements for binding of H. pylori to complex gangliosides. The human neutrophil gangliosides are a very complex mixture, and isolation of pure ganglioside species is difficult to achieve (32, 33) . Therefore, gangliosides were instead isolated from a range of different sources in which the occurrence of complex gangliosides has been described (e.g., human erythrocytes, bovine erythrocytes, rabbit thymus, human meconium, and human cancer tissues [34] ) and were characterized by mass spectrometry and proton nuclear magnetic resonance (NMR). Binding of representative sialic acid binding H. pylori strains, and mutant H. pylori strains with knockout of the sialic acid binding adhesin SabA and the neutrophil-activating protein HPNAP, to the gangliosides was assessed by means of the chromatogram binding assay.
MATERIALS AND METHODS
Ganglioside preparations. For the isolation of gangliosides, a number of tissues previously reported to contain complex gangliosides, e.g., human erythrocytes, bovine erythrocytes, rabbit thymus, human meconium, and human cancers (34), were collected. Isolation of total acid glycosphingolipid fractions was done as described previously (12) . Briefly, the tissues were lyophilized, followed by extraction in two steps with chloroform-methanol (2:1 and 9:1 [vol/vol]) in a Soxhlet apparatus. The material obtained was pooled and subjected to mild alkaline hydrolysis and dialysis, followed by separation on a silicic acid column. Acid and nonacid glycosphingolipids were separated on a DEAE column.
The acid glycosphingolipid fractions were separated by DEAE-Sepharose chromatography, followed by repeated silicic acid chromatography, and final separation was achieved using high-performance liquid chromatography on a Kromasil 5 silica column 250 mm long, with an inner diameter of 10 mm and a particle size of 5 m (Phenomenex, Torrance, Calif.), using linear gradients of chloroform-methanol-water (60:35:8 to 40:40:12 or 65:25:4 to 40:40:12 [vol/vol]) over 180 min, with a flow rate of 2 ml/min. The 2-ml fractions collected were analyzed by thin-layer chromatography and anisaldehyde staining (see below), and the H. pylori-binding activity was assessed using the chromatogram binding assay (see below). The fractions were pooled according to mobility on thin-layer chromatograms and their H. pylori-binding activities.
Reference glycosphingolipids. Reference glycosphingolipids were isolated and characterized at the Institute of Medical Biochemistry, Göteborg University, Göteborg, Sweden. Structural characterization was performed using proton NMR (15) , mass spectrometry (28) , and degradation studies (31, 40) . Sialyl-Le x hexaglycosylceramide was purchased from ARC, Edmonton, Canada.
Bacterial strains, growth conditions, and labeling. H. pylori strain CCUG 17874 was obtained from the Culture Collection of the University of Göteborg (CCUG). Strain J99 and the construction of the sabA(JHP662) mutant (designated the J99/SabA Ϫ mutant) were described previously (19) . The construction of the J99/NAP Ϫ mutant will be described elsewhere (M. Hurtig, unpublished data).
Bacteria were grown on brucella medium (Difco Laboratories, Irvine, Calif.) containing 10% fetal calf serum (Harlan Sera-Lab, Loughborough, United Kingdom) inactivated at 56°C and BBL IsoVitale X Enrichment (Becton Dickinson Microbiology Systems, Franklin Lakes, N.J.). The mutant strain J99/SabA Ϫ was cultured on the same medium supplemented with chloramphenicol (20 g/ml). Bacteria were radiolabeled by the addition of 50 Ci of [
35 S]methionine (Amersham Pharmacia Biotech, Little Chalfont, United Kingdom) diluted in 0.5 ml of phosphate-buffered saline (PBS), pH 7.3, to the culture plates. After incubation for 12 to 72 h at 37°C under microaerophilic conditions, the bacteria were harvested and centrifuged three times in PBS.
Alternatively, colonies were inoculated (10 5 CFU/ml) in Ham's F12 medium (Invitrogen Corp., Carlsbad, Calif.) supplemented with 10% heat-inactivated fetal calf serum and 50 Ci of [
35 S]methionine. The culture bottles were incubated with shaking under microaerophilic conditions at 37°C for 24 h. Bacterial cells were harvested by centrifugation and washed three times with PBS.
In both cases, the bacteria were finally resuspended in PBS containing 2% (wt/vol) bovine serum albumin (PBS-BSA) to ϳ10 8 CFU/ml. Both labeling procedures resulted in suspensions with specific activities of ϳ1 cpm per 100 H. pylori organisms.
Thin-layer chromatography. Total acid glycosphingolipid fractions (40 g) or pure gangliosides (0.0002 to 4 g) were separated on aluminum-backed silica gel 60 high-performance thin-layer chromatography plates (Merck, Darmstadt, Germany) using chloroform-methanol-water (60:35:8 [vol/vol/vol]) or chloroformmethanol-0.25% KCl in water (50:40:10 [vol/vol/vol]) as a solvent system. Chemical detection of glycosphingolipids on thin-layer chromatograms was carried out using anisaldehyde (39) or resorcinol (35) reagent.
Chromatogram binding assay. The chromatogram binding assay was essentially carried out as described previously (13) . Dried thin-layer chromatograms with separated glycosphingolipids were treated in 0.5% polyisobutylmethacrylate (wt/vol) (Aldrich Chemical Company Inc., Milwaukee, Wis.) in diethylethern-hexane (1:5 [vol/vol]) for 1 min and then air dried. To reduce nonspecific binding, the plates were incubated in PBS-BSA containing 0.1% (wt/vol) NaN 3 and 0.1% (vol/vol) Tween 20 at room temperature for 2 h. The plates were then incubated for 2 h at room temperature with 35 S-labeled H. pylori diluted in PBS-BSA. Following the final wash and drying, autoradiography was carried out overnight using Biomax film (Eastman Kodak Company, Rochester, N.Y.).
Derivatization of gangliosides.
Gangliosides were permethylated using sodium hydroxide and methyl iodide in dimethyl sulfoxide as described previously (16) . Reduction of permethylated samples was carried out using LiAlH 4 in diethylether (9) .
FAB and EI mass spectrometry. Negative-ion fast atom bombardment (FAB) and electron ionization (EI) mass spectra were obtained on an SX 102A mass spectrometer (JEOL, Toyko, Japan). Negative-ion FAB mass spectra of native gangliosides were obtained using Xe atom bombardment (6 eV), an acceleration voltage of Ϫ8 kV, and triethanolamine as a matrix. EI spectra of derivatized glycosphingolipids were obtained with an ionization voltage of 70 eV, an ionization current of 300 A, and an acceleration voltage of 8 kV. The temperature was raised from 150 to 410°C at a rate of 10°C/min. For the collection of both FAB and EI spectra, a resolution of 1,000 was used.
Proton NMR spectroscopy. 1H NMR spectra were acquired on Varian 500-and 600-MHz spectrometers at 30°C. The samples were dissolved in dimethyl sulfoxide-D 2 O (98:2 [vol/vol]) after deuterium exchange.
RESULTS

Ganglioside preparations.
To be able to dissect the ganglioside binding preferences of H. pylori, a ganglioside library was compiled (summarized in Table 1 ). Each ganglioside was characterized by mass spectrometry and proton NMR. The procedure is illustrated by the following description of the isolation and characterization of one H. pylori-binding ganglioside of human erythrocytes (Table 1 , no. 19).
Total acid glycosphingolipids were isolated from 500 liters of pooled outdated blood group B erythrocytes by standard procedures (12), yielding 5.5 g. A subfraction of 390 mg was separated on a 700-ml DEAE-Sepharose column eluted with a linear gradient using 2,100 ml of ammonium acetate in methanol (0.05 to 0.45 M). Each 10-ml fraction collected was analyzed by thin-layer chromatography using the resorcinol reagent. The fractions were pooled according to the mobilities of the major compounds. Pooling of fractions 62 to 67 yielded 15.4 mg, and the fraction obtained had a major compound migrating in the sialyl-neolactotetraosylceramide region. However, when it was tested for H. pylori-binding activity using the chromatogram binding assay, a slow-migrating binding-active compound was detected. The 15.4 mg of acid glycosphingolipids was further separated by high-performance liquid chromatography using a linear gradient of chloroform-methanol-water Since an internal NeuAc is unlikely, the result from negative-ion FAB mass spectrometry thus suggested a branched undecaosylceramide with a Hex-Fuc-Hex-HexNAc-(NeuAcHex-HexNAc)Hex-HexNAc-Hex-Hex sequence and a d18:1-24:0 ceramide. EI mass spectrometry of permethylated and LiAlH 4 -reduced H. pylori-binding ganglioside from human erythrocytes. EI mass spectrometry of permethylated and reduced glycosphingolipids gives dominant immonium ions, representing the complete carbohydrate chain and the fatty acid, along with rearrangement ions obtained by sequential loss of terminal carbohydrate units from the immonium ions (9) . In the spectrum of the permethylated and reduced ganglioside from human erythrocytes (Fig. 2) Proton NMR of H. pylori-binding ganglioside from human erythrocytes. The anomeric region of the 600-MHz proton NMR spectrum of the human erythrocyte ganglioside (Fig.  3A) is in agreement with a branched structure having the sugar composition indicated by mass spectrometry. In this anomeric region, two ␣ signals are evident at 5.15 and 4.97 ppm, which by comparison with earlier data on blood group B-active glycosphingolipids from human erythrocytes (4) can be ascribed to Fuc␣2 and Gal␣3 of a blood group B determinant. Irrespective of whether this determinant is located on the three-or six-linked branch of the structure, the anomeric signal of a Fuc␣2-and Gal␣3-substituted Gal␤4 is expected at 4.39 ppm, as is also observed. Furthermore, the presence of a GlcNAc␤ anomeric signal at 4. determinant is situated on the six-linked branch (4). Therefore, the sialic acid must be located on the three-linked branch, which is confirmed by the presence of two overlapping GlcNAc␤ signals, centered around 4.65 ppm, belonging to the GlcNAc residues of a neolactotetra core and three branch, respectively. The NeuAc residue is ␣3 linked, as seen by the presence of the H3eq resonance at 2.75 ppm (Fig. 3B) , and is attached to a Gal␤4 residue, as evidenced by the doublet at 4.19 ppm (8). The remaining anomeric signals stemming from the core are the branching Gal␤4 residue at 4.30 ppm, the second Gal␤4 residue at 4.26 ppm, and the Glc␤1 residue at 4.16 ppm, in accordance with earlier data (4, 8) . Additional resonances consistent with the assignments made above are found at 4.11 and 1.06 ppm (Fuc␣2 H5 and H6, respectively), as well as four methyl resonances from the N-acetamido moieties of the NeuAc residue (1.88 ppm) and the GlcNAc residues (1.84, 1.82, and 1.81 ppm). Overall, the spectral features are very similar to the corresponding spectrum of the blood group A-containing structure previously published (9) . Thus, by mass spectrometry and proton NMR of the H. pylori-binding ganglioside, a Gal␣3(Fuc␣2)Gal␤4GlcNAc␤6 (NeuAc␣3Gal␤4GlcNAc␤3)Gal␤4GlcNAc␤3Gal␤4Glc␤1Cer, i.e., a branched undecaglycosylceramide carrying a blood group B determinant on the ␤6-linked branch and a terminal sialic acid on the ␤3-linked branch, was identified. This ganglioside was previously characterized by Kannagi et 
al. and designated ganglioside G9-B (8).
Binding of H. pylori to ganglioside library. The H. pylori strains CCUG 17874 and J99, used in the chromatogram binding experiments, are both sialic acid binding (19) . In addition, two mutant strains were used, strain J99/SabA Ϫ , with knockout of the sialic acid binding adhesin SabA (19) , and strain J99/ NAP Ϫ , with knockout of the NeuAc␣3Gal␤4GlcNAc␤3Gal␤4 GlcNAc␤-binding neutrophil-activating protein of H. pylori, HPNAP (36) .
(i) Binding and nonbinding gangliosides. The results from binding of the H. pylori strains to the isolated gangliosides are shown in Fig. 4 to 8 and summarized in Table 1 . Gangliosides were classified as nonbinding when no binding was obtained although 4 g of the compound was on the thin-layer plates. As shown in Fig. 4 , the sialic acid binding wild-type strains CCUG 17874 and J99 recognized the NeuAc-terminated gangliosides NeuAc␣3Gal␤4GlcNAc␤3Gal␤4GlcNAc␤3Gal␤4Glc␤1Cer (NeuAc-neolactohexaocylceramide) (lane 1), NeuAc␣3 Gal␤4GlcNAc␤6(NeuAc␣3Gal␤4GlcNAc␤3)Gal␤4GlcNAc␤3 Gal␤4Glc␤1Cer (NeuAc-G-10 ganglioside) (lane 3), and Gal␣3(Fuc␣2)Gal␤4GlcNAc␤6(NeuAc␣3Gal␤4GlcNAc␤3) Gal␤4GlcNAc␤3Gal␤4Glc␤1Cer (G9-B ganglioside) (lane 6) but not the corresponding NeuGc-terminated isostructures (lanes 2, 4, and 5). Other gangliosides recognized were NeuAc␣3(Gal␤4GlcNAc␤3) 3 Gal␤4Glc␤1Cer (NeuAc-neolactooctaaocylceramide) (Fig. 6, lanes 1 to 7) , NeuAc␣3 Gal␤4GlcNAc␤3Gal␤4(Fuc␣3)GlcNAc␤3Gal␤4Glc␤1Cer (VIM-2 ganglioside) (Fig. 8, lanes 6 to 10) , and NeuAc␣3 Gal␤4(Fuc␣3)GlcNAc␤3Gal␤4(Fuc␣3)GlcNAc␤3Gal␤4Glc␤ 1Cer (sialyl-dimeric-Le x ganglioside) (Fig. 8, lanes 1 to 5) . Occasional binding to NeuAc␣3-neolactotetraosylceramide (Table 1 , no. 2, and Fig. 6, lanes 1 to 7) was also detected, while FIG. 2. EI mass spectrum of the permethylated and reduced H. pylori-binding ganglioside from human erythrocytes. Above the spectrum is a simplified formula for interpretation, representing the species with sphingosine and nonhydroxy 24:0 fatty acid. The analysis was done as described in Materials and Methods. The spectrum was recorded at 340°C.
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NeuAc␣6-neolactotetraosylceramide (Table 1, no. 3) was nonbinding, in line with previous reports (6, 20) . The NeuAc␣6-carrying gangliosides Gal␤4GlcNAc␤6(NeuAc␣6 Gal␤4GlcNAc␤3)Gal␤4Glc␤1Cer ( Fig. 4 and 5 ; summarized in Table 1 ). However, the J99/ 
SabA
Ϫ strain failed to bind to any of the gangliosides recognized by the parent strain ( Fig. 5E ; summarized in Table 1 ).
(ii) Comparison of relative binding affinities. Binding of radiolabeled H. pylori to glycosphingolipids diluted in microtiter wells was initially attempted in order to appreciate the relative binding affinities for the various binding-active gangliosides. However, the results obtained were not reproducible. Therefore, binding assays using dilutions of gangliosides on thin-layer plates were utilized. In initial experiments, we found that binding to NeuAc␣3-neolactohexaosylceramide and the NeuAc-dimeric-Le x ganglioside was saturated at ϳ100 pmol, and therefore, lower concentration ranges (1 to 100 pmol) were utilized. The results presented in Fig. 6 Fig. 7 , the blood group B type 2 epitope on the ␤6-linked branch of the G9-B ganglioside impaired binding compared to the linear NeuAc␣3-neolactohexaosylceramide. On the other hand, the NeuAc-G-10 ganglioside was the preferred ligand, which indicates that the NeuAc␣3Gal␤4GlcNAc sequence on the ␤6-linked branch in this case increased the binding affinity.
(c) Effects of fucose residues. To investigate the effects of fucose branches, the relative levels of binding of H. pylori strain CCUG 17874 to NeuAc␣3-neolactohexaosylceramide (Table  1 , no. 8), the VIM-2 ganglioside (Table 1 , no. 12), and the NeuAc␣3-dimeric-Le x ganglioside (Table 1 , no. 13) were compared. As shown in Fig. 8 , the bacteria bound with higher affinity to the VIM-2 and the NeuAc␣3-dimeric-Le x gangliosides than to NeuAc␣3-neolactohexaosylceramide.
DISCUSSION
Recognition of sialic acid-containing glycoconjugates by certain H. pylori strains has been repeatedly demonstrated (5, 6, 7, 19-22, 26, 27) . In the present study, a library of gangliosides was collected and used for dissection of H. pylori-binding preferences utilizing representative sialic acid-recognizing H. pylori strains and mutant strains with knockout of putative ganglioside binding proteins. Two ganglioside binding proteins of H. pylori have been identified, the SabA adhesin and the NeuAc␣3Gal␤4 GlcNAc␤3Gal␤4GlcNAc␤-binding neutrophil-activating protein HPNAP (19, 36) . HPNAP is a major immunogen of H. pylori (29) and is to some extent associated with the bacterial cell surface (2) . Since whole bacterial cells also bind to NeuAc␣3Gal␤4GlcNAc␤3Gal␤4GlcNAc␤-terminated glycosphingolipids, it is tempting to speculate that this interaction is due to surface-associated HPNAP. However, after knockout of the gene coding for HPNAP, the bacteria still recognized glycosphingolipids with terminal NeuAc␣3Gal␤4GlcNAc␤3 Gal␤4GlcNAc␤. The binding of NeuAc␣3Gal␤4GlcNAc␤3 Gal␤4GlcNAc␤-terminated gangliosides, as well as interaction with all other gangliosides, however, was lost after knockout of the gene for the SabA adhesin, demonstrating that ganglioside . The gangliosides were separated on aluminumbacked silica gel plates, using chloroform-methanol-0.25% KCl in water (50:40:10 [vol/vol/vol]) as a solvent system, and the binding assay was performed as described in Materials and Methods. Lanes 1, NeuAc␣3Gal␤4GlcNAc␤3Gal␤4GlcNAc␤3Gal␤4Glc␤1Cer (NeuAc␣3-neolactohexaocylceramide) of human hepatoma (2 g); lanes 2, NeuGc␣3Gal␤4GlcNAc␤3Gal␤4GlcNAc␤3Gal␤4Glc␤1Cer (NeuGc␣3-neolactohexaocylceramide) of rabbit thymus (2 g); lanes 3, NeuAc␣3Gal␤4GlcNAc␤6 (NeuAc␣3Gal␤4GlcNAc␤3)Gal␤4GlcNAc␤3Gal␤4Glc␤1Cer (NeuAc-G-10 ganglioside) of human erythrocytes (2 g); lanes 4, NeuGc␣3Gal␤4GlcNAc␤6 (NeuGc␣3Gal␤4GlcNAc␤3)Gal␤4GlcNAc␤3Gal␤4Glc␤1Cer (NeuGc-G-10 ganglioside) of bovine erythrocytes (2 g); lanes 5, Gal␣3Gal␤4GlcNAc␤6 (NeuGc␣3Gal␤4GlcNAc␤3)Gal␤4GlcNAc␤3 Gal␤4Glc␤1Cer of bovine erythrocytes (2 g); lanes 6, Gal␣3(Fuc␣2)Gal␤4GlcNAc␤6 (NeuAc␣3Gal␤4GlcNAc␤3)Gal␤4GlcNAc␤3Gal␤4Glc␤1Cer (G9-B ganglioside) of human erythrocytes (2 g). Autoradiography was performed for 12 h. An occasional binding of the J99 strain to sialyl-Le a hexaglycosylceramide was observed when 0.5 g was applied on the thin-layer plate. However, the CCUG 17874 strain did not bind to this ganglioside. Binding of the J99 strain to both sialyl-Le a and sialyl-Le x neoglycoproteins has also been demonstrated (19) . This indicates that the SabA carbohydrate binding sites of the J99 and the CCUG 17874 strains are not identical. However, in all other respects, the CCUG 17874 strain and the J99 strain bound to gangliosides in identical manners, and both strains recognized N-acetyllactosamine-based gangliosides with terminal NeuAc␣3, but not NeuAc␣6, in line with previous reports (6, 20) . Furthermore, gangliosides with terminal NeuGc␣3 or NeuAc␣8NeuAc␣3 were not recognized.
The factors that affected binding affinity were identified as (i) the length of the N-acetyllactosamine carbohydrate chain, (ii) the branches of the carbohydrate chain, and (iii) fucose substitution of the N-acetyllactosamine core chain.
N-Acetyllactosamine core length. Preferential binding of H. pylori to NeuAc␣3-neolactooctaosylceramide over NeuAc␣3-neolactohexaosylceramide and NeuAc␣3-neolactotetraosylceramide was observed. This effect is most likely due to improved accessibility of the carbohydrate head group when presented on a longer core chain.
Divalency. Cooperative binding may account for the increased affinity for the NeuAc-G-10 ganglioside, with two NeuAc␣3Gal␤4GlcNAc␤ branches, relative to the linear NeuAc␣3-neolactohexaosylceramide. This is in agreement with the report of Simon et al. (30) demonstrating that multivalent albumin conjugates of sialyl-lactose (NeuAc␣3 Gal␤4Glc) inhibited the adherence of H. pylori to epithelial monolayers more effectively than monovalent sialyl-lactose.
The lower binding affinity to the G9-B ganglioside than to , and J99/SabA Ϫ (E). The gangliosides were separated on aluminum-backed silica gel plates, using chloroform-methanol-0.25% KCl in water (50:40:10 [vol/vol/vol]) as a solvent system, and the binding assays were performed as described in Materials and Methods. Lanes 1, gangliosides of human neutrophil granulocytes (20 g); lanes 2, NeuGc␣3Gal␤4GlcNAc␤3Gal␤4GlcNAc␤3Gal␤4Glc␤1Cer (NeuGc␣3-neolactohexaocylceramide) of rabbit thymus (2 g); lanes 3, NeuAc␣3Gal␤4GlcNAc␤3Gal␤4GlcNAc␤3Gal␤4Glc␤1Cer (NeuAc␣3-neolactohexaocylceramide) of human hepatoma (1 g); lanes 4, NeuAc␣3Gal␤4GlcNAc␤6 (NeuAc␣3Gal␤4GlcNAc␤3)Gal␤4GlcNAc␤3Gal␤4Glc␤1Cer (NeuAc-G-10 ganglioside) of human erythrocytes (1 g); lanes 5, Gal␣3(Fuc␣2)Gal␤4GlcNAc␤6 (NeuAc␣3Gal␤4GlcNAc␤3)Gal␤4GlcNAc␤3Gal␤4Glc␤1Cer (G9-B ganglioside) of human erythrocytes (1 g); lanes 6, Gal␣3(Fuc␣2)Gal␤4GlcNAc␤3Gal␤4Glc␤1Cer (B6 type 2 hexaglycosylceramide) of human erythrocytes (4 g); lanes 7, Gal␤3GalNAc␤4Gal␤4Glc␤1Cer (gangliotetraosylceramide) of mouse feces (4 g). Autoradiography was performed for 12 to 24 h. NeuAc␣3-neolactohexaosylceramide shows that the blood group B determinant on the ␤6-linked branch interfered with the binding process. Still, there is no absolute hindrance, since the detection level for the G9-B ganglioside was ϳ100 pmol. This suggests that the H. pylori-binding determinants are mainly exposed on the ␤3 axis of the Gal␣3(Fuc␣2)Gal␤4 GlcNAc␤6(NeuAc␣3Gal␤4GlcNAc␤3)Gal␤4GlcNAc␤3Gal␤4 Glc␤1Cer structure.
Fucose branches on the N-acetyllactosamine core. The higher binding affinity for the VIM-2 ganglioside than forNeuAc␣-neolactohexaosylceramide suggests that the ␣-linked Fuc at the innermost GlcNAc contributes to the high-affinity binding of NeuAc␣-dimeric-Le
x . This fucose residue may either interact with the carbohydrate binding site of the SabA adhesin or affect the conformation of the ganglioside,providing optimal presentation of the head group. Resolution of this issue must, however, await the expression and crystallizationof the SabA adhesin.
Simon et al. have demonstrated that sialyl-lactose inhibits the binding of fresh H. pylori isolates to gastrointestinal epithelial cells and even promotes the detachment of bound bacteria (30) . Furthermore, oral administration of sialyl-lactose to H. pylori-infected rhesus monkeys had a curative effect in two out of six monkeys, and one monkey was transiently cleared of the infection (24) . The structural features required for highaffinity H. pylori ganglioside binding outlined above (i.e., repetitive N-acetyllactosamine units, fucose branches, and di-or multivalency) may be utilized for the construction of more efficient inhibitors of H. pylori adherence.
The expression of the SabA adhesin is, unlike that of the Le b -binding BabA adhesin, subject to phase variation (19) . Varying numbers of bacteria expressing the SabA adhesin within the bacterial-cell population used in the binding assays may account for the difficulties in determining an absolute affinity of binding for a given ganglioside. However, in repeated binding assays, the same relationships between the binding-active gangliosides were observed. The biological significance of these findings requires further study. Although the sialic acid content of the normal human gastric epithelium is very low (18) , gastric inflammation leads to an upregulation of the expression of sialic acid-containing glycoconjugates (20) . Our present hypothesis is thus that the initial attachment of H. pylori is achieved through binding to receptors present in the normal gastric epithelium, e.g., the Le b antigen and lactotetraosylceramide. The ensuing inflammation leads to enhanced expression of sialyltransferases in the gastric mucosa, ultimately providing novel binding sites for H. pylori SabA adhesin and thereby contributing to the chronicity of the infection. In addition, it was recently demonstrated that the nonopsonic H. pylori-induced activation of human neutrophils occurs by lectinophagocytosis, i.e., recognition of sialylated glycoconjugates on the neutrophil cell surface by a bacterial adhesin leads to phagocytosis and an oxidative burst with the production of reactive oxygen metabolites (37) . Thus, the sialic acid binding capacity of H. pylori may have a dual role. On one hand, it mediates adhesion of bacteria to the epithelium in the already diseased stomach, and on the other, it leads to the activation of neutrophils to an oxidative burst with the production of reactive oxygen metabolites and the release of biologically active enzymes, giving rise to further tissue damage. The use of the Varian 500-and 600-MHz machines at the Swedish NMR Centre, Hasselblad Laboratory, Göteborg University, is gratefully acknowledged.
